These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26332768)

  • 1. Seventh international French Society of Statistics meeting on statistical methods in biopharmacy: emerging topics for statistical methodology in clinical drug development.
    Bretz F
    Stat Med; 2015 Sep; 34(22):2981-2. PubMed ID: 26332768
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances and trends in statistics as applied to clinical trials. Proceedings of the Sixth International French Society of Statistics Meeting on Statistical Methods in Biopharmacy. September 2009. Paris, France.
    Stat Med; 2011 Jun; 30(13):1471-635. PubMed ID: 21998851
    [No Abstract]   [Full Text] [Related]  

  • 3. Sixth International French Society of Statistics meeting on statistical methods in biopharmacy: recent advances and trends in statistics as applied to clinical trials.
    Grouin JM; Campbell M
    Stat Med; 2011 Jun; 30(13):1471-2. PubMed ID: 21341303
    [No Abstract]   [Full Text] [Related]  

  • 4. Statistical innovations in clinical trials. Proceedings of the French Society of Statistics, Biopharmacy and Health Group Fifth International Meeting on Statistical Methods in Biopharmacy. September 26-27, 2005. Paris, France.
    Stat Med; 2007 Nov; 26(27):4843-5045. PubMed ID: 17929271
    [No Abstract]   [Full Text] [Related]  

  • 5. Guest editors' note: Special issue associated with the 2013 ASA Biopharmaceutical FDA/Industry Statistics Workshop.
    Binkowitz B; Yue LQ
    J Biopharm Stat; 2014; 24(5):965-7. PubMed ID: 25014118
    [No Abstract]   [Full Text] [Related]  

  • 6. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Issue of Journal of Biopharmaceutical Statistics dedicated to 2016 Trends and Innovations in Clinical Trial Statistics (TICTS) Conference.
    Davidian M; Ivanova A; Marchenko O
    J Biopharm Stat; 2017; 27(3):357. PubMed ID: 27977324
    [No Abstract]   [Full Text] [Related]  

  • 8. How well do multiple testing methods scale up when both n and k increase?
    Westfall PH; Manage A
    J Biopharm Stat; 2011 Jul; 21(4):583-94. PubMed ID: 21516558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Journal of Biopharmaceutical Statistics. From the editors.
    Hyslop T; Jung SH
    J Biopharm Stat; 2009; 19(3):413. PubMed ID: 19384684
    [No Abstract]   [Full Text] [Related]  

  • 10. 31st Annual Conference of the International Society for Clinical Biostatistics. Preface.
    Lesaffre E; Gerds T
    Stat Med; 2012 May; 31(11-12):1001. PubMed ID: 22585410
    [No Abstract]   [Full Text] [Related]  

  • 11. Statistical methods in biopharmacy. Satellite meeting of the 47th World Session of the International Statistical Institute. Paris, 7-8 September 1989. Proceedings.
    Stat Med; 1991 Jun; 10(6):807-999. PubMed ID: 1876773
    [No Abstract]   [Full Text] [Related]  

  • 12. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
    Segreti AC; Leung HM; Koch GG; Davis RL; Mohberg NR; Peace KE
    J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A group sequential approach to evaluation of bridging studies.
    Hsiao CF; Xu JZ; Liu JP
    J Biopharm Stat; 2003 Nov; 13(4):793-801. PubMed ID: 14584723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic equivalence--clinical issues and statistical methodology in noninferiority trials.
    Munk A; Trampisch HJ
    Biom J; 2005 Feb; 47(1):7-9; discussion 99-107. PubMed ID: 16395992
    [No Abstract]   [Full Text] [Related]  

  • 15. University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (morning panel session).
    Rockhold FW; Lindblad A; Siegel JP; Molenberghs G
    Clin Trials; 2019 Aug; 16(4):350-362. PubMed ID: 31303021
    [No Abstract]   [Full Text] [Related]  

  • 16. University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (afternoon panel session).
    Little RJ; Tchetgen EJT; Troxel AB
    Clin Trials; 2019 Aug; 16(4):381-390. PubMed ID: 31244326
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings of the University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis.
    Ellenberg SS; Ellenberg JH
    Clin Trials; 2019 Aug; 16(4):337-338. PubMed ID: 31244345
    [No Abstract]   [Full Text] [Related]  

  • 18. One-sided or two-sided p values: which most appropriately address the question of drug efficacy?
    Peace KE
    J Biopharm Stat; 1991; 1(1):133-8. PubMed ID: 1844684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: emerging statistical issues in the conduct and monitoring of clinical trials.
    Ellenberg JH; Ellenberg SS
    Clin Trials; 2012 Dec; 9(6):669-70. PubMed ID: 23250941
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies.
    Ponce R; Abad L; Amaravadi L; Gelzleichter T; Gore E; Green J; Gupta S; Herzyk D; Hurst C; Ivens IA; Kawabata T; Maier C; Mounho B; Rup B; Shankar G; Smith H; Thomas P; Wierda D
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):164-82. PubMed ID: 19345250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.